Pyrazole derivatives
    3.
    发明授权
    Pyrazole derivatives 失效
    吡唑衍生物

    公开(公告)号:US5670503A

    公开(公告)日:1997-09-23

    申请号:US505284

    申请日:1995-08-21

    CPC分类号: C07D487/04

    摘要: New heterocyclic derivatives of the formula: ##STR1## wherein R.sup.1 is aryl which may have suitable substituent(s) or heterocyclic group which may have suitable substituent(s), R.sup.2 is aryl which may have suitable substituent(s) or heterocyclic group which may have suitable substituent(s), R.sup.3 is hydrogen or acyl, R.sup.4 is hydrogen, lower alkyl, cyclo(lower)alkyl, cyclo(lower)alkyl-(lower)alkyl, carboxy(lower)alkyl, protected carboxy(lower)alkyl, ar(lower)alkyl which may have suitable substituent(s), ar(lower)alkenyl, bridged tricyclicalkyl, heterocyclic group which may have suitable substituent(s), acyl, or a group of the formula ##STR2## (in which A is lower alkylene), and R.sup.5 is hydrogen or lower alkyl, and a pharmaceutically acceptable salt thereof which are useful as a medicament.

    摘要翻译: PCT No.PCT / JP94 / 00213 Sec。 371日期1995年8月21日 102(e)日期1995年8月21日PCT 1994年2月9日PCT PCT。 公开号WO94 / 19350 PCT 日期1994年9月1日新的具有下式的杂环衍生物:可以具有合适取代基的可能的取代基或杂环基,R 2可以具有合适的取代基的芳基或可具有合适取代基的杂环基 ),R 3是氢或酰基,R 4是氢,低级烷基,环(低级)烷基,环(低级)烷基 - (低级)烷基,羧基(低级)烷基,被保护的羧基 其可以具有合适的取代基,芳(低级)烯基,桥连三环烷基,可具有合适取代基的杂环基,酰基或式(IMAGE)(其中A是低级亚烷基)的基团,以及 R5是可用作药物的氢或低级烷基及其药学上可接受的盐。

    Method of preparing certain 3-halo-imidazopyridines
    7.
    发明授权
    Method of preparing certain 3-halo-imidazopyridines 失效
    制备某些3-卤代 - 咪唑并吡啶的方法

    公开(公告)号:US5750699A

    公开(公告)日:1998-05-12

    申请号:US662198

    申请日:1996-06-12

    IPC分类号: C07D471/04 C07D471/02

    CPC分类号: C07D471/04

    摘要: The invention relates to bradykinin antagonists of the formula: ##STR1## wherein R.sup.1 is halogen, R.sup.2 and R.sup.3 are each hydrogen, lower alkyl, halo(lower)alkyl or acyl, R.sup.4 is aryl having suitable substituent(s), or a heterocyclic group optionally having suitable substituent(s), Q is O or N--R.sup.11, in which R.sup.11 is hydrogen or acyl, and A is lower alkylene, and pharmaceutically acceptable salts thereof.

    摘要翻译: 本发明涉及下式的缓激肽拮抗剂:其中R 1为卤素,R 2和R 3各自为氢,低级烷基,卤代(低级)烷基或酰基,R 4为具有合适取代基的芳基或杂环基 任选具有合适的取代基,Q是O或N-R 11,其中R 11是氢或酰基,A是低级亚烷基,及其药学上可接受的盐。